Assessment of Osseointegration Properties of Nano-Hydroxy Apatite Coated Titanium Implant

April 8, 2024 updated by: Mohamed Hamdy Mahmoud Ismail, October University for Modern Sciences and Arts

Assessment of Osseointegration Properties of Nano-Hydroxy Apatite Coated Titanium Implant Versus Sandblasted Large Thread Acid Etched Implants in Posterior Maxilla. A Randomized Clinical Trial

the purpose of this trial is to evaluate the osseointegration properties of nano-hydroxy apatite coated titanium implants in posterior maxilla. 30 patients will be included in this trial divided into two groups, control and intervention. Primary and secondary implant stability will be measured

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Mohamed Ha Mahmoud Ismail, PhD
  • Phone Number: +201002838699
  • Email: mmhamdy@msa.edu.eg

Study Locations

      • Giza, Egypt
        • October University for Modern Sciences and Arts faulty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Patients with missing at least one maxillary posterior tooth
  2. Patients free from any systemic disease
  3. Patients who approve to be included in the trial and sign the informed consent
  4. Patients with no intra-bony defect.
  5. Adults aged 18 years old and above

Exclusion Criteria:

  1. Patients who are allergic to titanium
  2. Heavy smoker patient
  3. Patients receiving chemotherapy or radiotherapy
  4. Patients who refused to be included in the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nano-hydroxy apatite arm
in this groups patients will receive nano-hydroxy apatite coated titanium implants
titanium implants with surface treatment of nano-hydroxy apatite
Active Comparator: SLA arm
in this group patients will receive sandblasted large thread acid etched titanium implants
titanium implants with SLA surface treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant stability
Time Frame: immediately post-operative
implant stability will be measured by radiofrequency analysis
immediately post-operative
Implant stability
Time Frame: 4 weeks post-operative
implant stability will be measured by radiofrequency analysis
4 weeks post-operative
Implant stability
Time Frame: 6 weeks post-operative
implant stability will be measured by radiofrequency analysis
6 weeks post-operative
Implant stability
Time Frame: 12 weeks post-operative
implant stability will be measured by radiofrequency analysis
12 weeks post-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mohamed H Mahmoud, PhD, october university for modern science and arts faculty of dentistry

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 22, 2023

Primary Completion (Actual)

April 1, 2024

Study Completion (Actual)

April 5, 2024

Study Registration Dates

First Submitted

June 22, 2023

First Submitted That Met QC Criteria

June 29, 2023

First Posted (Actual)

July 10, 2023

Study Record Updates

Last Update Posted (Actual)

April 9, 2024

Last Update Submitted That Met QC Criteria

April 8, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Implant Site Reaction

Clinical Trials on nano-hydroxy apatite coated titanium implants

3
Subscribe